Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Erbliche metabolische Nierenerkrankungen

Unter metabolischen Nierenerkrankungen wird eine breite Gruppe von Erkrankungen zusammengefasst, die durch metabolische Störungen charakterisiert ist, welche letztendlich zu renalen Symptomen führen können.

Gliederung

Erbliche Nierenerkrankungen
Angeborene Fehlbildungen des Urogenitalsystems
Erbliche metabolische Nierenerkrankungen
Hereditäre Amyloidose
ATTR-Amyloidose
TTR
Amyloidose vom Finnischen Typ
GSN
Cryopyrin-assoziiertes periodisches Fieber-Syndrom
CINCA-Syndrom
NLRP3
Familiäres kälteinduziertes autoinflammatorisches Syndrom 1
NLRP3
Muckle-Wells-Syndrom
NLRP3
Familiäres Mittelmeerfieber
MEFV
NOD2
SAA1
TNFRSF1A
Nierenamyloidose
APOA1
Apolipoprotine A2-Amyloidose
APOA2
B2M
CST3
FGA
LYZ
Zerebroarterielle Amyloidose
Zerebroarterielle Amyloidose vom Britischen Typ
ITM2B
Zerebroarterielle Amyloidose vom Dänischen Typ
ITM2B
Zerebroarterielle Amyloidose vom Holländischen Typ
APP
Zerebroarterielle Amyloidose vom Isländischen Typ
CST3
Hyperoxalurie
Hyperoxalurie vom Typ 1
AGXT
Hyperoxalurie vom Typ 2
GRHPR
Hyperoxalurie vom Typ 3
HOGA1
Lysinurische Proteinintoleranz
SLC7A7
Morbus Fabry
GLA
Hereditäre Nierentumoren
Hereditäre Tubulusfunktionsstörungen der Niere
Hereditäre Urolithiasis
Hereditäre glomeruläre Nierenerkrankungen
Interstitielle Nierenerkrankungen
Nierenerkrankungen mit endokrinologischer Manifestation
Thrombotische Mikroangiopathien
Zystische Nierenerkrankungen

Referenzen:

1.

Borsani G et al. (1999) SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance.

external link
2.

Purdue PE et al. (1990) Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1.

external link
3.

Aksentijevich I et al. (1999) Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population.

external link
4.

Mansfield E et al. (2001) The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments.

external link
5.

El-Shanti H et al. (2006) Familial mediterranean fever in Arabs.

external link
6.

Bonyadi M et al. (2009) MEFV mutations in Iranian Azeri Turkish patients with familial Mediterranean fever.

external link
7.

Yuval Y et al. (1995) Dominant inheritance in two families with familial Mediterranean fever (FMF).

external link
8.

None (1997) A candidate gene for familial Mediterranean fever.

external link
9.

None (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium.

external link
10.

Babior BM et al. (1997) The familial Mediterranean fever gene--cloned at last.

external link
11.

Belostotsky R et al. (2010) Mutations in DHDPSL are responsible for primary hyperoxaluria type III.

external link
12.

Cattan D et al. (2000) Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever.

external link
13.

Tamir N et al. (1999) Late-onset familial Mediterranean fever (FMF): a subset with distinct clinical, demographic, and molecular genetic characteristics.

external link
14.

Brik R et al. (2001) Incidence of familial Mediterranean fever (FMF) mutations among children of Mediterranean extraction with functional abdominal pain.

external link
15.

Milledge J et al. (2002) Allogeneic bone marrow transplantation: cure for familial Mediterranean fever.

external link
16.

None (2003) Should patients with FMF undergo BMT?

external link
17.

Touitou I et al. (2003) Allogenic bone marrow transplantation: not a treatment yet for familial Mediterranean fever.

external link
18.

Cazeneuve C et al. (2003) Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations.

external link
19.

HELLER H et al. (1961) Amyloidosis in familial Mediterranean fever. An independent genetically determined character.

external link
20.

DORMER AE et al. (1962) Familial Mediterranean fever: a cause of periodic fever.

external link
21.

None (1964) FAMILIAL PAROXYSMAL POLYSEROSITIS. ANALYSIS OF FIFTY CASES.

external link
22.

Shohat M et al. (1992) Twin studies in familial Mediterranean fever.

external link
23.

Shohat M et al. (1992) The gene for familial Mediterranean fever in both Armenians and non-Ashkenazi Jews is linked to the alpha-globin complex on 16p: evidence for locus homogeneity.

external link
24.

Pras E et al. (1992) Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16.

external link
25.

Sack GH et al. (1991) Exclusion of linkage between familial Mediterranean fever and the human serum amyloid A (SAA) gene cluster.

external link
26.

Touitou I et al. (2007) Transmission of familial Mediterranean fever mutations following bone marrow transplantation.

external link
27.

Papadopoulos VP et al. (2008) The population genetics of familial mediterranean fever: a meta-analysis study.

external link
28.

Shohat M et al. (1990) Serum amyloid A and P protein genes in familial Mediterranean fever.

external link
29.

Shohat T et al. (1990) Familial Mediterranean fever--linkage studies with genetic markers on chromosome 6.

external link
30.

Shohat T et al. (1990) Genetic marker family studies in familial Mediterranean fever (FMF) in Armenians.

external link
31.

Lazarin GA et al. (2013) An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.

external link
32.

Ayesh SK et al. (1990) Partial characterization of a C5a-inhibitor in peritoneal fluid.

external link
33.

Shohat M et al. (1989) Hypothesis: familial Mediterranean fever--a genetic disorder of the lipocortin family?

external link
34.

Majeed HA et al. (1989) Familial Mediterranean fever (recurrent hereditary polyserositis) in children: analysis of 88 cases.

external link
35.

Rogers DB et al. (1989) Familial Mediterranean fever in Armenians: autosomal recessive inheritance with high gene frequency.

external link
36.

None (1988) Serum amyloid A (SAA) gene variations in familial Mediterranean fever.

external link
37.

Schwabe AD et al. (1988) Meningitis in familial Mediterranean fever.

external link
38.

Benson MD et al. (1977) Amyloid deposition in a renal transplant in familial Mediterranean fever.

external link
39.

Barakat MH et al. (1986) Familial Mediterranean fever (recurrent hereditary polyserositis) in Arabs--a study of 175 patients and review of the literature.

external link
40.

Jones MB et al. (1977) Amyloidosis in a renal allograft in familial Mediterranean fever.

external link
41.

Eshel G et al. (1988) Acute orchitis in familial Mediterranean fever.

external link
42.

Barakat MH et al. (1988) Mollaret's meningitis. A variant of recurrent hereditary polyserositis, both provoked by metaraminol.

external link
43.

Zemer D et al. (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

external link
44.

Schwabe AD et al. (1987) Recurrent polyserositis (familial Mediterranean fever) in a Japanese.

external link
45.

Rubinger D et al. (1979) Amelioration of familial Mediterranean fever during hemodialysis.

external link
46.

Knecht A et al. (1985) Serum amyloid A protein in familial Mediterranean fever.

external link
47.

Schwabe AD et al. (1974) Familial Mediterranean Fever in Armenians. Analysis of 100 cases.

external link
48.

Zemer D et al. (1974) A controlled trial of colchicine in preventing attacks of familial mediterranean fever.

external link
49.

Dinarello CA et al. (1974) Colchicine therapy for familial mediterranean fever. A double-blind trial.

external link
50.

None (1972) Colchicine for familial Mediterranean fever.

external link
51.

Sohar E et al. (1967) Familial Mediterranean fever. A survey of 470 cases and review of the literature.

external link
52.

Hurwich BJ et al. (1970) Record survival of siblings with familial Mediterranean fever, phenotypes 1 and 2.

external link
53.

Reich CB et al. (1970) Familial Mediterranean fever in an Italian family.

external link
54.

Ozdemir AI et al. (1969) Familial Mediterranean fever among the Turkish people.

external link
55.

Barakat MH et al. (1984) Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever.

external link
56.

Cattan D et al. (1984) Metaraminol provocation test for familial Mediterranean fever.

external link
57.

Barakat MH et al. (1984) Diagnosing familial Mediterranean fever.

external link
58.

Ilfeld D et al. (1982) Correction of a suppressor cell deficiency in four patients with familial Mediterranean fever by in vitro or in vivo colchicine.

external link
59.

Matzner Y et al. (1984) Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever.

external link
60.

Agmon D et al. () Isolated adrenal mineralocorticoid deficiency due to amyloidosis associated with familial Mediterranean fever.

external link
61.

Schlesinger M et al. (1984) Familial Mediterranean fever: no linkage with HLA.

external link
62.

Matzner Y et al. (1984) C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever.

external link
63.

Schwabe AD et al. (1984) C5a-inhibitor deficiency--a role in familial Mediterranean fever?

external link
64.

None (1983) Enrollment bias and variation in clinical manifestations: a review of consecutive cases of familial paroxysmal polyserositis.

external link
65.

Pras M et al. (1982) Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups.

external link
66.

Flatau E et al. (1982) Schönlein-Henoch syndrome in patients with familial Mediterranean fever.

external link
67.

Ludomirsky A et al. (1981) Amyloidosis in children with familial Mediterranean fever.

external link
68.

Daniels M et al. (1995) Familial Mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel.

external link
69.

Pras E et al. (1994) The gene causing familial Mediterranean fever maps to the short arm of chromosome 16 in Druze and Moslem Arab families.

external link
70.

Ozyilkan E et al. (1994) Absence of asthma in patients with familial Mediterranean fever.

external link
71.

Aksentijevich I et al. (1993) Refined mapping of the gene causing familial Mediterranean fever, by linkage and homozygosity studies.

external link
72.

Aksentijevich I et al. (1993) Evidence for linkage of the gene causing familial Mediterranean fever to chromosome 17q in non-Ashkenazi Jewish families: second locus or type I error?

external link
73.

Fischel-Ghodsian N et al. (1993) Regional mapping of the gene for familial Mediterranean fever on human chromosome 16p13.

external link
74.

Zemer D et al. (1993) Familial Mediterranean fever in the colchicine era: the fate of one family.

external link
75.

Levy EN et al. (1996) Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.

external link
76.

Ben-Chetrit E et al. (1996) Colchicine in breast milk of patients with familial Mediterranean fever.

external link
77.

None (1996) Localization of the familial Mediterranean fever gene (FMF) to a 250-kb interval in non-Ashkenazi Jewish founder haplotypes. The French FMF Consortium.

external link
78.

None (1977) Familial Mediterranean fever. Recent advances in pathogenesis and management.

external link
79.

Rawashdeh MO et al. (1996) Familial Mediterranean fever in Arab children: the high prevalence and gene frequency.

external link
80.

Dupont M et al. (1997) Genotypic diagnosis of familial Mediterranean fever (FMF) using new microsatellite markers: example of two extensive non-Ashkenazi Jewish pedigrees.

external link
81.

Sood R et al. (1997) Construction of a 1-Mb restriction-mapped cosmid contig containing the candidate region for the familial Mediterranean fever locus (MEFV) on chromosome 16p 13.3.

external link
82.

Ravid M et al. (1977) Prolonged colchicine treatment in four patients with amyloidosis.

external link
83.

Akarsu AN et al. (1997) Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population.

external link
84.

Saatçi U et al. (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis.

external link
85.

Pras E et al. (1998) Clinical differences between North African and Iraqi Jews with familial Mediterranean fever.

external link
86.

Yazigi A et al. (1998) Colchicine for recurrent pericarditis in children.

external link
87.

Germain DP et al. (1999) Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.

external link
88.

Ohshima T et al. (1999) Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice.

external link
89.

Schiffmann R et al. (2000) Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

external link
90.

Takenaka T et al. (2000) Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells.

external link
91.

Asano N et al. (2000) In vitro inhibition and intracellular enhancement of lysosomal alpha-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives.

external link
92.

Brady RO et al. (2000) Clinical features of and recent advances in therapy for Fabry disease.

external link
93.

Ioannou YA et al. (2001) Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice.

external link
94.

Prigozy TI et al. (2001) Glycolipid antigen processing for presentation by CD1d molecules.

external link
95.

Eng CM et al. (2001) A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies.

external link
96.

Jung SC et al. (2001) Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice.

external link
97.

Qin G et al. (2001) Preselective gene therapy for Fabry disease.

external link
98.

Schiffmann R et al. (2001) Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

external link
99.

Pastores GM et al. (2001) Enzyme-replacement therapy for Anderson-Fabry disease.

external link
100.

None (2001) Co-occurrence and contribution of Fabry disease and Klippel-Trénaunay-Weber syndrome to a patient with atypical skin lesions.

external link
101.

MacDermot KD et al. (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.

external link
102.

MacDermot KD et al. (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

external link
103.

Whybra C et al. (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

external link
104.

Branton MH et al. (2002) Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

external link
105.

Romeo G et al. (1972) Genetic heterogeneity of alpha-galactosidase in fabry's disease.

external link
106.

Heltianu C et al. (2002) Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease.

external link
107.

Takahashi H et al. (2002) Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer.

external link
108.

Germain DP et al. (2002) Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients.

external link
109.

Blom D et al. (2003) Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA.

external link
110.

Senechal M et al. (2003) Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.

external link
111.

None (2003) PR interval and the response to enzyme-replacement therapy for Fabry's disease.

external link
112.

Nakao S et al. (2003) Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.

external link
113.

WISE D et al. (1962) Angiokeratoma corporis diffusum. A clinical study of eight affected families.

external link
114.

SWEELEY CC et al. (1963) FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID.

external link
115.

HAMBURGER J et al. (1964) [ON AN UNUSUAL FAMILIAL MALFORMATION OF THE RENAL EPITHELIUM].

external link
116.

RAHMAN AN et al. (1961) Angiokeratoma corporis diffusum universale (hereditary dystopic lipidosis).

external link
117.

Wilcox WR et al. (2004) Long-term safety and efficacy of enzyme replacement therapy for Fabry disease.

external link
118.

Verovnik F et al. (2004) Remarkable variability in renal disease in a large Slovenian family with Fabry disease.

external link
119.

Spinelli L et al. (2004) Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.

external link
120.

Germain DP et al. (2005) Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease.

external link
121.

Rolfs A et al. (2005) Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study.

external link
122.

Prüss H et al. (2006) Paroxysmal vertigo as the presenting symptom of Fabry disease.

external link
123.

Nagao Y et al. (1991) Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.

external link
124.

Nance CS et al. (2006) Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.

external link
125.

Mastropasqua L et al. (2006) Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study.

external link
126.

Spada M et al. (2006) High incidence of later-onset fabry disease revealed by newborn screening.

external link
127.

Kirkilionis AJ et al. (1991) Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.

external link
128.

Faggiano A et al. (2006) Endocrine dysfunction in patients with Fabry disease.

external link
129.

Eng CM et al. (2006) Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

external link
130.

Kaneski CR et al. (2006) Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease.

external link
131.

Wang RY et al. (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life.

external link
132.

Kim W et al. (2007) Pulmonary manifestations of Fabry disease and positive response to enzyme replacement therapy.

external link
133.

Moore DF et al. (2007) The cerebral vasculopathy of Fabry disease.

external link
134.

None (2007) Narrative review: Fabry disease.

external link
135.

Opitz JM et al. (1965) The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus.

external link
136.

Auray-Blais C et al. (2008) Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease.

external link
137.

Aerts JM et al. (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

external link
138.

von Scheidt W et al. (1991) An atypical variant of Fabry's disease with manifestations confined to the myocardium.

external link
139.

Fellgiebel A et al. (2009) Diagnostic utility of different MRI and MR angiography measures in Fabry disease.

external link
140.

Mehta A et al. (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey.

external link
141.

Waldek S et al. (2009) Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.

external link
142.

Tajima Y et al. (2009) Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.

external link
143.

Crosbie TW et al. (2009) Psychological aspects of patients with Fabry disease.

external link
144.

Testai FD et al. (2010) Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

external link
145.

None () [Not Available].

external link
146.

None (1946) [Not Available].

external link
147.

Beaudet AL et al. (1978) Detection of Fabry's disease heterozygotes by hair root analysis.

external link
148.

Ogawa K et al. (1990) Restricted accumulation of globotriaosylceramide in the hearts of atypical cases of Fabry's disease.

external link
149.

Kornreich R et al. (1990) Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene.

external link
150.

Hasholt L et al. (1990) A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations.

external link
151.

Bird TD et al. (1978) Neurological manifestations of Fabry disease in female carriers.

external link
152.

Elleder M et al. (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy.

external link
153.

Spence MW et al. (1978) Angiokeratoma corporis diffusum (Anderson-Fabry disease) in a single large family in Nova Scotia.

external link
154.

Hamers MN et al. (1979) Relationship between biochemical and clinical features in an English Anderson-Fabry family.

external link
155.

Bernstein HS et al. (1989) Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.

external link
156.

MacDermot KD et al. (1987) Anderson Fabry disease, a close linkage with highly polymorphic DNA markers DXS17, DXS87 and DXS88.

external link
157.

Rodriguez FH et al. (1985) Fabry's disease in a heterozygous woman.

external link
158.

Hasholt L et al. (1986) Lysosomal alpha-galactosidase in endothelial cell cultures established from a Fabry hemizygous and normal umbilical veins.

external link
159.

Lemansky P et al. (1987) Synthesis and processing of alpha-galactosidase A in human fibroblasts. Evidence for different mutations in Fabry disease.

external link
160.

Efthimiou J et al. (1986) Short PR intervals and tachyarrhythmias in Fabry's disease.

external link
161.

Sakuraba H et al. (1986) Cardiovascular manifestations in Fabry's disease. A high incidence of mitral valve prolapse in hemizygotes and heterozygotes.

external link
162.

Friedlaender MM et al. (1987) Renal biopsy in Fabry's disease eight years after successful renal transplantation.

external link
163.

Mutoh T et al. (1988) Severe orthostatic hypotension in a female carrier of Fabry's disease.

external link
164.

Ropers HH et al. (1977) Evidence for preferential X-chromosome inactivation in a family with Fabry disease.

external link
165.

Peltier A et al. (1977) Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.

external link
166.

Loonen MC et al. (1974) Letter: Angiokeratoma corporis diffusum and lysosomal enzyme deficiency.

external link
167.

Roudebush CP et al. (1973) The abbreviated PR interval of Fabry's disease.

external link
168.

Mapes CA et al. (1970) Enzyme replacement in Fabry's disease, an inborn error of metabolism.

external link
169.

Flynn DM et al. (1972) Gut lesions in Fabry's disease without a rash.

external link
170.

Patel V et al. (1972) Deficiency of alpha-L-fucosidase.

external link
171.

Johnston AW et al. (1969) Linkage relationships of the angiokeratoma (Fabry) locus.

external link
172.

None (1970) Fabry's disease: alpha-galactosidase deficiency.

external link
173.

Romeo G et al. (1970) Genetic inactivation of the alpha-galactosidase locus in carriers of Fabry's disease.

external link
174.

Clarke JT et al. (1971) Ceramide trihexosidosis (fabry's disease) without skin lesions.

external link
175.

Philippart M et al. (1969) Urinary glycolipids in Fabry's disease. Their examination in the detection of atypical variants and the pre-symptomatic state.

external link
176.

Franceschetti AT et al. (1969) A study of Fabry's disease. I. Clinical examination of a family with cornea verticillata.

external link
177.

Frost P et al. (1966) Fabry's disease--glycolipid lipidosis. Histochemical and electron microscopic studies of two cases.

external link
178.

Brady RO et al. (1967) Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

external link
179.

Rosenberg DM et al. (1980) Chronic airflow obstruction in Fabry's disease.

external link
180.

Broadbent JC et al. (1981) Fabry cardiomyopathy in the female confirmed by endomyocardial biopsy.

external link
181.

Sheth KJ et al. (1981) Heterozygote detection in Fabry disease utilizing multiple enzyme activities.

external link
182.

Johnston AW et al. (1981) Linkage relationship of the loci for Anderson--Fabry disease and the Xg blood groups.

external link
183.

Cable WJ et al. (1982) Fabry disease: significance of ultrastructural localization of lipid inclusions in dermal nerves.

external link
184.

Tagliavini F et al. (1982) Anderson-Fabry's disease: neuropathological and neurochemical investigation.

external link
185.

Bach G et al. (1982) Pseudodeficiency of alpha-galactosidase A.

external link
186.

Clement M et al. (1982) Renal transplantation in Anderson-Fabry disease.

external link
187.

Cable WJ et al. (1982) Fabry disease: detection of heterozygotes by examination of glycolipids in urinary sediment.

external link
188.

None (1982) [Fabry's disease. Light and electron microscopic cardiac findings 12 years after successful kidney transplantation].

external link
189.

Friedman LS et al. (1984) Jejunal diverticulosis with perforation as a complication of Fabry's disease.

external link
190.

Maisey DN et al. (1980) Basilar artery aneurysm and Anderson-Fabry disease.

external link
191.

Sørensen SA et al. (1980) alpha-Galactosidase isozymes in normal individuals, and in Fabry hemizygotes and heterozygotes.

external link
192.

Pyeritz RE et al. (1980) Plasma exchange removes glycosphingolipid in Fabry disease.

external link
193.

Faraggiana T et al. (1981) Light- and electron-microscopic histochemistry of Fabry's disease.

external link
194.

Cable WJ et al. (1982) Fabry disease: impaired autonomic function.

external link
195.

Colucci WS et al. (1982) Hypertrophic obstructive cardiomyopathy due to Fabry's disease.

external link
196.

Novo FJ et al. (1995) Editing of human alpha-galactosidase RNA resulting in a pyrimidine to purine conversion.

external link
197.

Eng CM et al. (1993) Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.

external link
198.

Nakao S et al. (1995) An atypical variant of Fabry's disease in men with left ventricular hypertrophy.

external link
199.

Hillsley RE et al. (1995) Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease.

external link
200.

Elleder M et al. (1994) Leptomeningeal lipid storage patterns in Fabry disease.

external link
201.

Eng CM et al. (1994) Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.

external link
202.

Halsted CH et al. (1975) Letter: Occurrence of celiac sprue in a patient with Fabry's disease.

external link
203.

Spence MW et al. (1976) Failure to correct the metabolic defect by renal allotransplantion in Fabry's disease.

external link
204.

Pierides AM et al. (1976) Study on a family with anderson--Fabry's disease and associated familial spastic paraplegia.

external link
205.

Davies JP et al. (1993) Mutation analysis in patients with the typical form of Anderson-Fabry disease.

external link
206.

Ko YH et al. (1996) Atypical Fabry's disease. An oligosymptomatic variant.

external link
207.

Ishii S et al. (1996) Aggregation of the inactive form of human alpha-galactosidase in the endoplasmic reticulum.

external link
208.

Sawada K et al. (1996) Point mutation in the alpha-galactosidase A gene of atypical Fabry disease with only nephropathy.

external link
209.

Blanch LC et al. (1996) A sensitive mutation screening strategy for Fabry disease: detection of nine mutations in the alpha-galactosidase A gene.

external link
210.

Germain D et al. (1996) Fluorescence-assisted mismatch analysis (FAMA) for exhaustive screening of the alpha-galactosidase A gene and detection of carriers in Fabry disease.

external link
211.

Brown LK et al. (1997) Pulmonary involvement in Fabry disease.

external link
212.

Ohshima T et al. (1997) alpha-Galactosidase A deficient mice: a model of Fabry disease.

external link
213.

Fan JQ et al. (1999) Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor.

external link
214.

Norio R et al. (1971) Lysinuric protein intolerance, an autosomal recessive disease. A genetic study of 10 Finnish families.

external link
215.

Torrents D et al. (1999) Identification of SLC7A7, encoding y+LAT-1, as the lysinuric protein intolerance gene.

external link
216.

Sperandeo MP et al. (1999) Feasibility of prenatal diagnosis of lysinuric protein intolerance by linkage analysis: a case report.

external link
217.

Pirulli D et al. (1999) Molecular analysis of hyperoxaluria type 1 in Italian patients reveals eight new mutations in the alanine: glyoxylate aminotransferase gene.

external link
218.

Cramer SD et al. (1999) The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.

external link
219.

Walden U et al. (1999) Primary hyperoxaluria 1: catch up growth and normalization of oxaluria 6 years after hepatorenal transplantation in a prepubertal boy.

external link
220.

Cochat P et al. (1999) Primary hyperoxaluria in infants: medical, ethical, and economic issues.

external link
221.

Mykkänen J et al. (2000) Functional analysis of novel mutations in y(+)LAT-1 amino acid transporter gene causing lysinuric protein intolerance (LPI).

external link
222.

Noguchi A et al. (2000) SLC7A7 genomic structure and novel variants in three Japanese lysinuric protein intolerance families.

external link
223.

Simell O et al. (1975) Lysinuric protein intolerance.

external link
224.

Theodossiadis PG et al. (2002) Choroidal neovascularization in primary hyperoxaluria.

external link
225.

FREDERICK EW et al. (1963) STUDIES ON PRIMARY HYPEROXALURIA. I. IN VIVO DEMONSTRATION OF A DEFECT IN GLYOXYLATE METABOLISM.

external link
226.

Sperandeo MP et al. (2008) Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene.

external link
227.

Font-Llitjós M et al. (2009) Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat.

external link
228.

Williams EL et al. (2009) Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.

external link
229.

Purdue PE et al. (1991) Mistargeting of peroxisomal L-alanine:glyoxylate aminotransferase to mitochondria in primary hyperoxaluria patients depends upon activation of a cryptic mitochondrial targeting sequence by a point mutation.

external link
230.

Nishiyama K et al. (1991) Primary hyperoxaluria type I due to a point mutation of T to C in the coding region of the serine:pyruvate aminotransferase gene.

external link
231.

Seargeant LE et al. (1991) Primary oxaluria type 2 (L-glyceric aciduria): a rare cause of nephrolithiasis in children.

external link
232.

Wang RY et al. (2011) Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals.

external link
233.

Latta K et al. (1990) Primary hyperoxaluria type I.

external link
234.

Small KW et al. (1990) Ocular findings in primary hyperoxaluria.

external link
235.

Takada Y et al. (1990) Human peroxisomal L-alanine: glyoxylate aminotransferase. Evolutionary loss of a mitochondrial targeting signal by point mutation of the initiation codon.

external link
236.

Van Schaftingen E et al. (1989) Coenzyme specificity of mammalian liver D-glycerate dehydrogenase.

external link
237.

Shaw PJ et al. (1989) Familial lysinuric protein intolerance presenting as coma in two adult siblings.

external link
238.

McDonald JC et al. (1989) Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect.

external link
239.

Danpure CJ et al. (1987) Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity.

external link
240.

Danpure CJ et al. (1988) Prenatal exclusion of primary hyperoxaluria type 1.

external link
241.

Danpure CJ et al. (1989) An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria.

external link
242.

Danpure CJ et al. (1986) Mitochondrial damage and the subcellular distribution of 2-oxoglutarate:glyoxylate carboligase in normal human and rat liver and in the liver of a patient with primary hyperoxaluria type I.

external link
243.

Smith DW et al. (1988) Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes.

external link
244.

Danpure CJ et al. (1988) Further studies on the activity and subcellular distribution of alanine:glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type 1.

external link
245.

Baethge BA et al. (1988) Livedo reticularis and peripheral gangrene associated with primary hyperoxaluria.

external link
246.

Danpure CJ et al. (1986) Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I.

external link
247.

Watts RW et al. (1985) Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

external link
248.

Carpenter TO et al. (1985) Lysinuric protein intolerance presenting as childhood osteoporosis. Clinical and skeletal response to citrulline therapy.

external link
249.

Yendt ER et al. (1985) Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.

external link
250.

Kihara H et al. (1973) Hyperdibasicaminoaciduria in a mentally retarded homozygote with a peculiar response to phenothiazines.

external link
251.

Perheentupa J et al. (1965) Protein intolerance with deficient transport of basic aminoacids. Another inborn error of metabolism.

external link
252.

Williams HE et al. (1971) Hyperoxaluria in L-glyceric aciduria: possible pathogenic mechanism.

external link
253.

Will EJ et al. (1979) Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy.

external link
254.

Boquist L et al. (1973) Primary oxalosis.

external link
255.

Klauwers J et al. (1969) Failure of renal transplantation in primary oxalosis.

external link
256.

Bourke E et al. (1972) Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.

external link
257.

Koch J et al. (1967) Deficiency of 2-oxo-glutarate: glyoxylate carboligase activity in primary hyperoxaluria.

external link
258.

Oyanagi K et al. (1970) Congenital lysinuria: a new inherited transport disorder of dibasic amino acids.

external link
259.

Dent CE et al. (1970) Treatment of primary hyperoxaluria.

external link
260.

None (1970) [Heredity of familial oxalosis].

external link
261.

Malmquist J et al. (1971) Familial protein intolerance. Possible nature of enzyme defect.

external link
262.

Coltart DJ et al. (1971) Primary oxalosis of the heart: a cause of heart block.

external link
263.

Williams HE et al. (1968) L-glyceric aciduria. A new genetic variant of primary hyperoxaluria.

external link
264.

Kekomäki M et al. (1968) Familial protein intolerance with deficient transport of basic amino acids. Report on an adult patient with chronic hyperammonemia.

external link
265.

Hockaday TD et al. (1965) The metabolic error in primary hyperoxaluria.

external link
266.

Kekomäki M et al. (1967) Familial protein intolerance with deficient transport of basic amino acids. An analysis of 10 patients.

external link
267.

Massie BM et al. (1981) Primary oxalosis with pan-conduction cardiac disease: electrophysiologic and anatomic correlation.

external link
268.

Berger A et al. (1984) More on neuropathy from pyridoxine abuse.

external link
269.

Dennis AJ et al. (1980) Nitroglycerin as a remedy for peripheral vascular insufficiency associated with oxalosis.

external link
270.

Rajantie J et al. (1980) Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine.

external link
271.

Kato T et al. (1982) Renal transport of lysine and arginine in lysinuric protein intolerance.

external link
272.

Chesney RW et al. (1983) Renal failure with hypercalcemia, renal stones, multiple pathologic fractures, and growth failure.

external link
273.

O'Regan PF et al. (1980) Primary hyperoxaluria.

external link
274.

Morris MC et al. (1982) Oxalosis in infancy.

external link
275.

Rajantie J et al. (1981) Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.

external link
276.

Milliner DS et al. (1994) Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria.

external link
277.

Parto K et al. (1994) Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients.

external link
278.

None (1993) Primary hyperoxaluria type 1 and peroxisome-to-mitochondrion mistargeting of alanine:glyoxylate aminotransferase.

external link
279.

McManus DT et al. (1996) Necropsy findings in lysinuric protein intolerance.

external link
280.

Danpure CJ et al. (1996) Strategies for the prenatal diagnosis of primary hyperoxaluria type 1.

external link
281.

Parsons H et al. (1996) Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance.

external link
282.

Lauteala T et al. (1997) Lysinuric protein intolerance (LPI) gene maps to the long arm of chromosome 14.

external link
283.

Kemper MJ et al. (1997) Primary hyperoxaluria type 2.

external link
284.

None (1998) Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I.

external link
285.

Lauteala T et al. () Genetic homogeneity of lysinuric protein intolerance.

external link
286.

Duval M et al. (1999) Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance.

external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz